Episode

Could Ozempic, and other GLP-1 drugs, be changing more than your waistline?

Podcast: Newell Normand
Published: Jul 10, 2026
Duration seconds: 963
Processing state: not_requested
Canonical source: https://player.amperwavepodcasting.com?feed-link=https%3A%2F%2Frss.amperwave.net%2Fv2%2Fepisode%2F8502664_2026-07-10-170204
Audio: https://serve.castfire.com/audio/8502664/8502664_2026-07-10-170204.128.mp3?rssID=3856
JSON: /v1/public/podcasts/newell-normand-2482167/episodes/could-ozempic-and-other-glp-1-drugs-be-changing-more-than-your-waistline
Markdown: /podcast/newell-normand-2482167/could-ozempic-and-other-glp-1-drugs-be-changing-more-than-your-waistline.md

Actions

POST https://stenobird.com/v1/public/podcasts/newell-normand-2482167/episodes/could-ozempic-and-other-glp-1-drugs-be-changing-more-than-your-waistline/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/newell-normand-2482167/could-ozempic-and-other-glp-1-drugs-be-changing-more-than-your-waistline.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

New research suggests popular GLP-1 drugs may also affect the brain’s reward and impulse-control systems. What does it mean for patients, and could these medications have uses beyond weight loss? Newell has on Dr. Gil Hebert, Assistant Professor of Medicine at Tulane University, to talk about it.